Results 121 to 130 of about 16,190 (245)

Duloxetine: The Next Gold Standard for Treating Depression and Motor Symptoms in Parkinson's Disease? [PDF]

Actas Esp Psiquiatr
Nogueira GN.
europepmc   +1 more source

Depression and executive dysfunction after stroke [PDF]

, 2005
Vataja, Risto
core  

Antidepressants for people with epilepsy and depression [PDF]

, 2014
Adams, Alper, Bagdy, Baker, Boylan, Cotterman-Hart, Coupland, Gilliam, Guyatt, Hamid, Hermann, Hesdorffer, Hesdorffer, Hesdorffer, Hesdorffer, Indaco, Jacoby, Kirkham, Klerman, Kondziella, Lambert, Lin, Mendez, Mula, Mula, Preskorn, Sackeim, Stahl, Sterne, Tellez-Zenteno, Trimble, Wroblewski, Zarate   +32 more
core   +1 more source

Are Antidepressants Mood Agents Or Anxiolytic Drugs? [PDF]

SOJ Pharmacy & Pharmaceutical Sciences, 2018
openaire   +2 more sources

Antidepressants and risk of postural hypotension: a self-controlled case series study in UK primary care. [PDF]

Br J Gen Pract
Bhanu C, Walters K, Orlu M, Davis D, Sofat R, Petersen I.   +5 more
europepmc   +1 more source

TRPV3: time to decipher a poorly understood family member! [PDF]

, 2017
Bíró, Tamás, Nilius, Bernd, Owsianik, Grzegorz   +2 more
core   +1 more source

Characterization of tricyclic anti-depressant drugs efficacy via topological indices. [PDF]

Sci Rep
Kour S, Sankar JR.
europepmc   +1 more source

Inhaled sevoflurane use for myoclonic status secondary to bupropion intoxication. [PDF]

Crit Care Sci
Canasiro AR, Park M, Cardozo Junior LCM, Vilar GR, Hajjar LA.   +4 more
europepmc   +1 more source

The Future of Oncology in Psychiatric Medications. [PDF]

J Clin Med
Waszkiewicz N.
europepmc   +1 more source

Activation of glutamine synthetase (GS) as a new strategy for the treatment of major depressive disorder and other GS-related diseases. [PDF]

Acta Pharmacol Sin
Kang JS, Kim H, Baek JH, Song M, Park H, Jeong W, Chung HJ, Yoo DY, Lee DK, Park SW, Kim HJ.   +10 more
europepmc   +1 more source